bosutinib monohydrate
SpainDrugs containing this active substance
-
Form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 100 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either newly diagnosed in the chronic phase, or in cases where other medications have not worked or are not suitable. It is also used in adults with Ph+ CML in the accelerated or blast phase when previous treatments have not been effective.
Form: capsules, hard
Active substance Dosage bosutinib monohydrate 103,40 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either in newly diagnosed chronic phase or in accelerated or blast phase when other medicines have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 413,6 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), either in newly diagnosed chronic phase or in accelerated or blast phase, for whom other medicines have not been effective or are not suitable.
Form: capsules, hard
Active substance Dosage bosutinib monohydrate 51,70 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat adults and children aged 6 years and older with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in newly diagnosed chronic phase, or for those for whom other medicines have not worked or are not suitable. It is also used in adults with Ph+ CML in accelerated phase or blast phase when other treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage bosutinib monohydrate 500 mg Manufacturer: Pfizer Europe Ma Eeig